Latest filing published 25 Mar 2021 for Coegin Pharma, €9,304.
Insider track record
No signal scores available.
Lars Persson: trading record in brief
Lars Persson discloses dealings in Coegin Pharma to Finansinspektionen. In total, 2 filings cover trades dated 23 March 2021.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 25 March 2021, reports a share grant of €9,304 in Coegin Pharma. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Lars Persson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 295,400 shares@ SEK 0.3289.4% of flowBTA (betald tecknad aktie)ISIN SE0012570190FI:csv-8f9cb2b861d697d4c9d3
- 35,000 shares@ SEK 0.3210.6% of flowBTA (betald tecknad aktie)ISIN SE0012570190FI:csv-3c920010c64d321f9169
2 of 2 declarations